M&A Deal Summary

Huma Acquires BioBeats Group

On April 16, 2020, Huma acquired information technology company BioBeats Group

Acquisition Highlights
  • This is Huma’s 2nd transaction in the Information Technology sector.
  • This is Huma’s 2nd transaction in the United Kingdom.

M&A Deal Summary

Date 2020-04-16
Target BioBeats Group
Sector Information Technology
Buyer(s) Huma
Deal Type Add-on Acquisition

Target

BioBeats Group

London, United Kingdom
BioBeats Group Ltd. is a London-based company dedicated to building validated digital mental health interventions and leading a new approach to wellbeing support through its flagship product, BioBase. The mobile app, paired with biosensors and a wearable device, gathers biometric data (e.g. heart rate variability) and psychometric measures (e.g. mood journaling) to provide users with a personalized wellbeing score, fostering an increased understanding of their mental wellbeing. Combining applied research and AI, BioBase improves mental health through tailored insights, biofeedback tools and digital therapeutics for a preventative mental health intervention.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Huma

London, United Kingdom

Category Company
Founded 2011
Sector Information Technology
DESCRIPTION

Huma Ltd. partners with scientists, technologists and healthcare professionals to understand, treat and ultimately prevent ill health. Giving knowledge and power to those with medical conditions, while saving clinicians time, energy and valuable resources. Because, by collectively benefiting from the data we individually generate, we can all live our longest, fullest lives. Huma was founded in 2011 and is based in London, United Kingdom.


DEAL STATS #
Overall 3 of 3
Sector: Information Technology M&A 2 of 2
Type: Add-on Acquisition M&A Deals 3 of 3
Country: United Kingdom M&A 2 of 2
Year: 2020 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-04-16 Tarilian Laser Technologies

Welwyn Garden City, United Kingdom

Tarilian Laser Technologies Ltd. is a medical technology company focused on providing an innovative breakthrough in blood pressure monitoring with an unobtrusive wearable device on a person’s wrist. This novel sensor utilizes light modulation to detect motion, including continuous beat-by-beat flow motion forces that determine arterial blood pressure. Through this new, clinically-validated technology, it provides continuous blood pressure monitoring without a cuff. TLT was formed in 2006 and is based in Welwyn Garden City, United Kingdom.

Buy -